Orchestra BioMed Holdings's market cap is currently ―. The company's EPS TTM is $-1.479; its P/E ratio is -3.18; Orchestra BioMed Holdings is scheduled to report earnings on May 10, 2024, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 594.00K	$ 419.00K	$ 728.00K	$ 1.02M	-
Gross Profit	$ 259.00K	$ 378.00K	$ 915.00K	$ 1.21M	-
EBIT	$ -11.18M	$ -14.21M	$ -13.05M	$ 14.10M	$ -876.72K
EBITDA	$ -9.53M	$ -15.01M	$ -13.84M	$ 13.31M	$ -876.72K
Net Income Common Stockholders	$ -38.23M	$ -13.30M	$ -12.05M	$ 14.45M	$ -876.72K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 87.59M	$ 108.85M	$ 117.77M	$ 127.23M	$ 175.16K
Total Assets	$ 95.21M	$ 116.36M	$ 125.88M	$ 136.28M	$ 68.08M
Total Debt	$ 1.69M	$ 11.46M	$ 11.60M	$ 11.74M	$ 0.00
Net Debt	$ -85.91M	$ -97.39M	$ -106.17M	$ -115.50M	$ -175.16K
Total Liabilities	$ 27.17M	$ 36.70M	$ 36.44M	$ 36.53M	$ 7.34M
Stockholders Equity	$ 68.04M	$ 79.66M	$ 89.44M	$ 99.75M	$ -6.94M
Cash Flow	-
Free Cash Flow	$ -10.97M	$ -10.30M	$ -10.69M	$ -14.25M	$ -560.06K
Operating Cash Flow	$ -10.97M	$ -10.28M	$ -10.66M	$ -14.21M	$ -560.06K
Investing Cash Flow	$ 33.15M	$ 12.95M	$ 8.12M	$ -43.53M	-
Financing Cash Flow	$ -10.70M	$ 4.00K	$ 86.00K	$ 56.82M	-

Currency in USD

Orchestra BioMed Holdings Earnings and Revenue History

Income Statement >

Orchestra BioMed Holdings Debt to Assets

Balance Sheet >

Orchestra BioMed Holdings Cash Flow

Cash Flow >

Orchestra BioMed Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing